HDAC6 inhibition ameliorates sensory hypersensitivity and reduces immune cell signatures in the dorsal root ganglia in murine chronic pain models
Molecular Pharmacology · 2025
DOI: 10.1016/j.molpha.2025.100034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmacology, 2025. Verfasst von Ilinca M Giosan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Physiology, & Biophysics, Chobanian and Avedisian School of Medicine at Boston University, Boston, Massachusetts; Departm…. Hauptthemen laut MEDLINE: Ganglia, Spinal, Histone Deacetylase 6, Histone Deacetylase Inhibitors, Chronic Pain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Physiology, & Biophysics, Chobanian and Avedisian School of Medicine at Boston University, Boston, Massachusetts; Department of Anatomy, Animal Physiology and Biophysics, Faculty of Biology a…
- Department of Pharmacology, Physiology, & Biophysics, Chobanian and Avedisian School of Medicine at Boston University, Boston, Massachusetts; Nash Family Department of Neuroscience and Freidman Brain Institute, Icahn Sc…
- Nash Family Department of Neuroscience and Freidman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
- Department of Pharmacology, Physiology, & Biophysics, Chobanian and Avedisian School of Medicine at Boston University, Boston, Massachusetts.
- Department of Anatomy, Animal Physiology and Biophysics, Faculty of Biology and Interdisciplinary School of Doctoral Studies, University of Bucharest, Bucharest, Romania.
- Department of Pharmacology, Physiology, & Biophysics, Chobanian and Avedisian School of Medicine at Boston University, Boston, Massachusetts. Electronic address: vzachar@bu.edu.
Förderung
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Giosan, I. M., Serafini, R. A., Ramakrishnan, A., Tuffy, M. J., Zimering, J., Babes, A., Shen, L., & Zachariou, V. (2025). HDAC6 inhibition ameliorates sensory hypersensitivity and reduces immune cell signatures in the dorsal root ganglia in murine chronic pain models. Molecular Pharmacology. https://doi.org/10.1016/j.molpha.2025.100034
Vancouver
Giosan IM, Serafini RA, Ramakrishnan A, Tuffy MJ, Zimering J, Babes A, et al. HDAC6 inhibition ameliorates sensory hypersensitivity and reduces immune cell signatures in the dorsal root ganglia in murine chronic pain models. Molecular Pharmacology. 2025. doi:10.1016/j.molpha.2025.100034
BibTeX
@article{Giosan2025,
author = {Giosan, Ilinca M and Serafini, Randal A and Ramakrishnan, Aarthi and Tuffy, Madden J and Zimering, Jeffrey and Babes, Alexandru and Shen, Li and Zachariou, Venetia},
title = {HDAC6 inhibition ameliorates sensory hypersensitivity and reduces immune cell signatures in the dorsal root ganglia in murine chronic pain models},
journal = {Molecular Pharmacology},
year = {2025},
doi = {10.1016/j.molpha.2025.100034}
}
EUVIMED